CRL Annual Operating Profit
$617.26 M
-$33.71 M-5.18%
30 December 2023
Summary:
As of January 21, 2025, CRL annual operaing income is $617.26 million, with the most recent change of -$33.71 million (-5.18%) on December 30, 2023. During the last 3 years, it has risen by +$184.53 million (+42.64%). CRL annual operating profit is now -5.18% below its all-time high of $650.98 million, reached on December 31, 2022.CRL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Operating Profit
$117.41 M
-$34.25 M-22.58%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly operating income is $117.41 million, with the most recent change of -$34.25 million (-22.58%) on September 28, 2024. Over the past year, it has dropped by -$15.52 million (-11.67%). CRL quarterly operating profit is now -37.35% below its all-time high of $187.41 million, reached on June 25, 2022.CRL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM Operating Profit
$527.96 M
-$34.10 M-6.07%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM operating income is $527.96 million, with the most recent change of -$34.10 million (-6.07%) on September 28, 2024. Over the past year, it has dropped by -$89.31 million (-14.47%). CRL TTM operating profit is now -21.21% below its all-time high of $670.09 million, reached on March 1, 2023.CRL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.2% | -11.7% | -14.5% |
| 3 y3 years | +42.6% | -11.7% | -14.5% |
| 5 y5 years | +86.3% | -11.7% | -14.5% |
CRL Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.2% | +4.6% | -37.4% | at low | -21.2% | at low |
| 5 y | 5-year | -5.2% | +75.8% | -37.4% | +52.9% | -21.2% | +50.4% |
| alltime | all time | -5.2% | +1647.4% | -37.4% | +238.2% | -21.2% | +3366.1% |
Charles River Laboratories International Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $117.41 M(-22.6%) | $527.96 M(-6.1%) |
| June 2024 | - | $151.65 M(+20.4%) | $562.05 M(-2.3%) |
| Mar 2024 | - | $125.98 M(-5.2%) | $575.35 M(-6.8%) |
| Dec 2023 | $617.26 M(-5.2%) | $132.92 M(-12.3%) | $617.26 M(-4.8%) |
| Sept 2023 | - | $151.50 M(-8.1%) | $648.15 M(+0.1%) |
| June 2023 | - | $164.94 M(-1.8%) | $647.62 M(-3.4%) |
| Mar 2023 | - | $167.89 M(+2.5%) | $670.09 M(+2.9%) |
| Dec 2022 | $650.98 M(+10.4%) | $163.81 M(+8.5%) | $650.98 M(-1.4%) |
| Sept 2022 | - | $150.98 M(-19.4%) | $659.97 M(-0.7%) |
| June 2022 | - | $187.41 M(+26.0%) | $664.80 M(+8.1%) |
| Mar 2022 | - | $148.78 M(-13.9%) | $614.94 M(+4.3%) |
| Dec 2021 | $589.86 M(+36.3%) | $172.81 M(+10.9%) | $589.86 M(+8.0%) |
| Sept 2021 | - | $155.80 M(+13.3%) | $545.98 M(+4.4%) |
| June 2021 | - | $137.55 M(+11.2%) | $522.93 M(+13.2%) |
| Mar 2021 | - | $123.70 M(-4.1%) | $462.15 M(+6.8%) |
| Dec 2020 | $432.73 M(+23.2%) | $128.93 M(-2.9%) | $432.73 M(+4.9%) |
| Sept 2020 | - | $132.75 M(+72.9%) | $412.59 M(+10.7%) |
| June 2020 | - | $76.77 M(-18.6%) | $372.64 M(-0.8%) |
| Mar 2020 | - | $94.28 M(-13.3%) | $375.64 M(+7.0%) |
| Dec 2019 | $351.15 M(+6.0%) | $108.79 M(+17.2%) | $351.15 M(+1.8%) |
| Sept 2019 | - | $92.80 M(+16.3%) | $344.84 M(+2.5%) |
| June 2019 | - | $79.77 M(+14.3%) | $336.40 M(+0.9%) |
| Mar 2019 | - | $69.79 M(-31.9%) | $333.35 M(+0.6%) |
| Dec 2018 | $331.38 M(+15.0%) | $102.48 M(+21.5%) | $331.38 M(+13.6%) |
| Sept 2018 | - | $84.36 M(+10.0%) | $291.73 M(+3.7%) |
| June 2018 | - | $76.71 M(+13.1%) | $281.43 M(-1.7%) |
| Mar 2018 | - | $67.83 M(+8.0%) | $286.40 M(-0.7%) |
| Dec 2017 | $288.28 M(+21.4%) | $62.83 M(-15.2%) | $288.28 M(-2.2%) |
| Sept 2017 | - | $74.06 M(-9.3%) | $294.68 M(+5.5%) |
| June 2017 | - | $81.69 M(+17.2%) | $279.41 M(+9.2%) |
| Mar 2017 | - | $69.71 M(+0.7%) | $255.79 M(+7.7%) |
| Dec 2016 | $237.55 M(+15.1%) | $69.22 M(+17.7%) | $237.55 M(+7.7%) |
| Sept 2016 | - | $58.80 M(+1.3%) | $220.60 M(+1.5%) |
| June 2016 | - | $58.06 M(+12.8%) | $217.24 M(+1.1%) |
| Mar 2016 | - | $51.47 M(-1.5%) | $214.92 M(+4.1%) |
| Dec 2015 | $206.45 M(+16.2%) | $52.27 M(-5.7%) | $206.45 M(+5.9%) |
| Sept 2015 | - | $55.44 M(-0.5%) | $194.95 M(+5.0%) |
| June 2015 | - | $55.73 M(+29.6%) | $185.68 M(+2.6%) |
| Mar 2015 | - | $43.01 M(+5.5%) | $180.97 M(+1.9%) |
| Dec 2014 | $177.67 M(+17.4%) | $40.77 M(-11.7%) | $177.67 M(+10.0%) |
| Sept 2014 | - | $46.17 M(-9.5%) | $161.51 M(+3.4%) |
| June 2014 | - | $51.02 M(+28.5%) | $156.18 M(+5.3%) |
| Mar 2014 | - | $39.71 M(+61.4%) | $148.34 M(-2.0%) |
| Dec 2013 | $151.40 M(-8.7%) | $24.61 M(-39.8%) | $151.40 M(-6.5%) |
| Sept 2013 | - | $40.84 M(-5.4%) | $161.86 M(+2.0%) |
| June 2013 | - | $43.19 M(+1.0%) | $158.70 M(-3.7%) |
| Mar 2013 | - | $42.76 M(+21.9%) | $164.79 M(-0.6%) |
| Dec 2012 | $165.76 M | $35.07 M(-6.9%) | $165.76 M(-7.8%) |
| Sept 2012 | - | $37.68 M(-23.5%) | $179.84 M(+0.3%) |
| June 2012 | - | $49.27 M(+12.7%) | $179.25 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $43.74 M(-11.0%) | $183.29 M(+0.8%) |
| Dec 2011 | $181.80 M(+42.2%) | $49.14 M(+32.5%) | $181.80 M(-6.2%) |
| Sept 2011 | - | $37.09 M(-30.4%) | $193.88 M(+18.8%) |
| June 2011 | - | $53.31 M(+26.2%) | $163.25 M(+16.7%) |
| Mar 2011 | - | $42.25 M(-31.0%) | $139.92 M(+9.4%) |
| Dec 2010 | $127.87 M(-24.6%) | $61.22 M(+846.5%) | $127.87 M(+26.3%) |
| Sept 2010 | - | $6.47 M(-78.4%) | $101.26 M(-27.3%) |
| June 2010 | - | $29.98 M(-0.7%) | $139.24 M(-12.9%) |
| Mar 2010 | - | $30.19 M(-12.8%) | $159.91 M(-5.7%) |
| Dec 2009 | $169.61 M(-32.2%) | $34.61 M(-22.1%) | $169.61 M(-8.0%) |
| Sept 2009 | - | $44.45 M(-12.3%) | $184.27 M(-11.4%) |
| June 2009 | - | $50.66 M(+27.0%) | $208.00 M(-8.2%) |
| Mar 2009 | - | $39.89 M(-19.0%) | $226.65 M(-9.4%) |
| Dec 2008 | $250.24 M(+10.1%) | $49.27 M(-27.7%) | $250.24 M(-1.1%) |
| Sept 2008 | - | $68.17 M(-1.6%) | $253.10 M(+1.8%) |
| June 2008 | - | $69.31 M(+9.2%) | $248.56 M(+5.3%) |
| Mar 2008 | - | $63.49 M(+21.8%) | $235.98 M(+3.9%) |
| Dec 2007 | $227.19 M(+20.7%) | $52.13 M(-18.1%) | $227.19 M(+3.2%) |
| Sept 2007 | - | $63.63 M(+12.2%) | $220.21 M(+5.6%) |
| June 2007 | - | $56.73 M(+3.7%) | $208.50 M(+4.5%) |
| Mar 2007 | - | $54.70 M(+21.1%) | $199.48 M(+233.5%) |
| Dec 2006 | $188.17 M(+1.9%) | $45.15 M(-13.0%) | $59.81 M(+9.5%) |
| Sept 2006 | - | $51.92 M(+8.8%) | $54.61 M(+4.7%) |
| June 2006 | - | $47.70 M(-156.1%) | $52.18 M(-2.5%) |
| Mar 2006 | - | -$84.96 M(-312.7%) | $53.54 M(-70.9%) |
| Dec 2005 | $184.69 M(+16.9%) | $39.95 M(-19.3%) | $183.90 M(+5.2%) |
| Sept 2005 | - | $49.49 M(+0.9%) | $174.84 M(+3.6%) |
| June 2005 | - | $49.06 M(+8.1%) | $168.72 M(+3.0%) |
| Mar 2005 | - | $45.40 M(+47.0%) | $163.87 M(+3.7%) |
| Dec 2004 | $157.99 M(+14.0%) | $30.89 M(-28.8%) | $157.99 M(-2.8%) |
| Sept 2004 | - | $43.37 M(-1.9%) | $162.54 M(+5.9%) |
| June 2004 | - | $44.20 M(+11.9%) | $153.42 M(+6.4%) |
| Mar 2004 | - | $39.52 M(+11.5%) | $144.22 M(+4.1%) |
| Dec 2003 | $138.55 M(+13.3%) | $35.44 M(+3.5%) | $138.55 M(+3.3%) |
| Sept 2003 | - | $34.26 M(-2.1%) | $134.06 M(+1.3%) |
| June 2003 | - | $35.01 M(+3.4%) | $132.33 M(+3.6%) |
| Mar 2003 | - | $33.85 M(+9.3%) | $127.70 M(+4.4%) |
| Dec 2002 | $122.27 M(+35.4%) | $30.95 M(-4.8%) | $122.27 M(+7.5%) |
| Sept 2002 | - | $32.52 M(+7.0%) | $113.72 M(+8.1%) |
| June 2002 | - | $30.38 M(+6.9%) | $105.21 M(+5.9%) |
| Mar 2002 | - | $28.41 M(+26.8%) | $99.32 M(+10.0%) |
| Dec 2001 | $90.28 M(+38.8%) | $22.41 M(-6.7%) | $90.28 M(+10.6%) |
| Sept 2001 | - | $24.01 M(-2.0%) | $81.65 M(+8.2%) |
| June 2001 | - | $24.49 M(+26.4%) | $75.48 M(+9.1%) |
| Mar 2001 | - | $19.37 M(+40.7%) | $69.20 M(+6.4%) |
| Dec 2000 | $65.06 M(+51.4%) | $13.77 M(-22.9%) | $65.06 M(+26.8%) |
| Sept 2000 | - | $17.85 M(-2.0%) | $51.29 M(+53.4%) |
| June 2000 | - | $18.21 M(+19.6%) | $33.45 M(+119.6%) |
| Mar 2000 | - | $15.23 M | $15.23 M |
| Dec 1999 | $42.96 M(+21.6%) | - | - |
| Dec 1998 | $35.33 M | - | - |
FAQ
- What is Charles River Laboratories International annual operaing income?
- What is the all time high annual operating profit for Charles River Laboratories International?
- What is Charles River Laboratories International annual operating profit year-on-year change?
- What is Charles River Laboratories International quarterly operating income?
- What is the all time high quarterly operating profit for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly operating profit year-on-year change?
- What is Charles River Laboratories International TTM operating income?
- What is the all time high TTM operating profit for Charles River Laboratories International?
- What is Charles River Laboratories International TTM operating profit year-on-year change?
What is Charles River Laboratories International annual operaing income?
The current annual operating profit of CRL is $617.26 M
What is the all time high annual operating profit for Charles River Laboratories International?
Charles River Laboratories International all-time high annual operaing income is $650.98 M
What is Charles River Laboratories International annual operating profit year-on-year change?
Over the past year, CRL annual operaing income has changed by -$33.71 M (-5.18%)
What is Charles River Laboratories International quarterly operating income?
The current quarterly operating profit of CRL is $117.41 M
What is the all time high quarterly operating profit for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly operating income is $187.41 M
What is Charles River Laboratories International quarterly operating profit year-on-year change?
Over the past year, CRL quarterly operating income has changed by -$15.52 M (-11.67%)
What is Charles River Laboratories International TTM operating income?
The current TTM operating profit of CRL is $527.96 M
What is the all time high TTM operating profit for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM operating income is $670.09 M
What is Charles River Laboratories International TTM operating profit year-on-year change?
Over the past year, CRL TTM operating income has changed by -$89.31 M (-14.47%)